Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twistâmediated CD10 expression
Sign Up to like & getrecommendations! Published in 2018 at "Environmental Toxicology"
DOI: 10.1002/tox.22551
Abstract: Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, especially, in eastern Asia, and its prognosis is poor once metastasis occurs. Niclosamide, a US Food and Drug Administrationâapproved antihelmintic drug, was… read more here.
Keywords: hepatocellular carcinoma; antihelmintic drug; hcc; cd10 expression ... See more keywords